-

Yourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment in NIPT Workflows Following Prolonged Blood Storage in EDTA Tubes

  • Extended EDTA blood tube storage offers improved flexibility and cost-saving in NIPT workflows
  • Collaborative study with Tommy’s Charity and St Mary’s NHS Hospital, Manchester
  • Data presented at ISPD 2023 in Edinburgh, UK

MANCHESTER, England--(BUSINESS WIRE)--Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today presented data demonstrating that prolonged storage of blood in EDTA tubes is compatible with non-invasive prenatal testing (NIPT) when using size selection to enrich the fetal fraction. Scalable and precise DNA size selection following EDTA tube usage offers a cost-efficient alternative to the use of more expensive blood collection tubes (BCTs) and improves next-generation sequencing (NGS) workflows, reducing the risk of failed screening tests for expectant mothers. The data is currently being presented at the 27th International Conference on Prenatal Diagnosis and Therapy (ISPD) in Edinburgh, UK on 19th June 2023.

The collaborative study with Tommy’s Charity and St Mary’s NHS Hospital (Manchester, UK) used Yourgene’s IONA® Nx NIPT Workflow, a fully validated clinical workflow which utilises NGS to estimate the trisomy risk in the fetus. The workflow incorporates the unique size-selection capability of the company’s proprietary Ranger® Technology to collect DNA library material within a defined size range. This step enriches the fetal-derived cell-free DNA (cfDNA) fragments in samples by reducing the number of larger maternal DNA fragments. In addition, Yourgene has a patent pending in relation to the EDTA capability that has been filed.

Many NIPT clinics and hospitals take a maternal blood sample with an expensive BCT, such as a Streck tube, and the sample is stable for up to 14 days. However, the data presented has shown the capability to use EDTA tubes, which are commonly used and a significantly lower cost, with proven stability up to 7 days.

Sample stability and handling are crucial elements in the preservation of acceptable levels of fetal fraction and ultimately, the successful use of NIPT. Cell lysis due to sample instability can result in the release of maternal genomic DNA, which dilutes the fetal-derived cfDNA, thereby reducing the fetal fraction. The results of the study demonstrate that size selection can be used to recover the fetal fraction from whole blood stored in EDTA tubes over a prolonged period that exceeds the previous limit of 8 hours.

Dr Joanne Mason, Chief Scientific Officer at Yourgene Health, said: “The results of Yourgene’s study with Tommy’s and St Mary’s Hospital greatly improve the feasibility of EDTA tube usage in NIPT, particularly in situations where delayed transport of samples between collection site and analysis locations may occur. There’s also a considerable saving in the cost of the blood stabilising tubes, and associated licensing fees in the US. This offers greater flexibility and choice to labs and clinicians, while providing patients with fast, safe, and accurate screening results.”

Visit the poster (programme ID P-94) titled “A study to demonstrate that prolonged storage of blood in EDTA tubes is compatible with NIPT when using size selection to enrich fetal fraction” presented at ISPD taking place from 18–21 June. Copies of the poster will also be available to download from Yourgene’s website: https://yourgenehealth.com/our-products/instruments/lightbench-detect/#pac_dtm_child_2

For more information about Yourgene’s IONA Nx NIPT Workflow and its proprietary Ranger Technology, visit: https://yourgenehealth.com/our-products/instruments/lightbench-detect/#pac_dtm_child_0

Please contact Codon Communications for a high-resolution image.

Contacts

Codon Communications
Dr Michelle Ricketts
Tel: +44 7789 053885
Email: michelle.ricketts@codoncommunications.com

Yourgene Health

LSE:YGEN
Details
Headquarters: Manchester, UK
CEO: Lyn Rees
Employees: 201-500
Organization: PUB

Release Summary
Yourgene Health demonstrates prolonged storage of blood in EDTA tubes is compatible with NIPT when using size selection to enrich fetal fraction.
Release Versions
$Cashtags

Contacts

Codon Communications
Dr Michelle Ricketts
Tel: +44 7789 053885
Email: michelle.ricketts@codoncommunications.com

Social Media Profiles
More News From Yourgene Health

Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia

MANCHESTER, England & BOGOTÁ, Colombia--(BUSINESS WIRE)--Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Colombia at Genetix, a high-tech medical organisation specialised in human genetic diagnosis. Genetix introduced its NipTest at a launch event held in Bogotá, Colombia yesterday evening to raise awareness of this new local NIPT provision to clinicians in the...

Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco

MANCHESTER, England & RABAT, Morocco--(BUSINESS WIRE)--Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing....

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

MANCHESTER, England & SINGAPORE--(BUSINESS WIRE)--Yourgene Health launches MagBench™ Automated DNA Extraction Instrument and Kit. Available to Sage™ customers across Asia-Pacific and the Middle East....
Back to Newsroom